FDA Adverse Event Injury Summary report: N

XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 1982733 · Received February 9, 2011

Report

Report Number
2024168-2011-00783
Event Type
Injury
Date Received
February 9, 2011
Date of Event
December 13, 2010
Report Date
January 17, 2011
Manufacturer
AV-TEMECULA-CT
Product Code
NIQ
PMA / PMN Number
P070015
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE EVENT, PATIENT AND DEVICE INFORMATION. THE STENT REMAINS INSIDE THE PATIENT. THERE WAS NO REPORTED PRODUCT DEFICIENCY. ANGINA, ISCHEMIA, AND RESTENOSIS ARE KNOWN ADVERSE EVENTS AS LISTED IN THE XIENCE V INSTRUCTIONS FOR USE. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECTS AND THE RELATIONSHIP TO THE DEVICE, IF ANY, CANNOT BE DETERMINED, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURE, DESIGN, OR LABELING.

Description of Event or Problem · 1

IT WAS REPORTED VIA A TRIAL THAT ON (B)(6) 2010 THE PATIENT UNDERWENT STENTING IN THE PRE-DILATED PROXIMAL LEFT CIRCUMFLEX ARTERY WITH ONE 2.75 X 15 MM XIENCE V STENT. ON (B)(6) 2010, THE PATIENT WAS FOUND TO HAVE STABLE ANGINA, A (B)(4) STUDY, AND IN-STENT RESTENOSIS IN THE INDEX TARGET LESION. ON (B)(6) 2010, THE PATIENT UNDERWENT PERCUTANEOUS CORONARY INTERVENTION (PTCI) TO TREAT THE RESTENOSIS. THE EVENT RESOLVED ON (B)(6) 2010 AND THE PATIENT WAS DISCHARGED. THERE WAS NO ADVERSE PATIENT SEQUELA. THERE WAS NO ADDITIONAL INFORMATION PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM DRUG ELUTING CORONARY STENT SYSTEM NIQ AV-TEMECULA-CT 0010642

Patients

Seq Age Sex Outcome Treatment
1 71 YR Hospitalization| R